Michael C. Motal [1] , Daniel A. Klaus [1] , Diana Lebherz-Eichinger [1] , Bianca Tudor [1] , Thomas Hamp [2] , Marion Wiegele [2] , Rudolf Seemann [3] , Claus G. Krenn [1] , Georg A. Roth [*] [1]

Show more about author

Introduction

 

Sepsis is a major health care problem, responsible for approximately 10% of all intensive care unit (ICU) admissions. It is associated with long hospitalization times and poor patient outcome (1-3). Due to recent advances in training and prompt initiation of anti-microbial therapy, the mortality rates of septic shock, which were once as high as 80 percent, have been reduced to 20 to 30 percent (1,4).

Visceral adipose tissue is suspected to play a pathophysiological role in the development of systemic inflammation during sepsis. Adipocytokines are cytokines secreted by adipose tissue. A sepsis-specific profile of adipocytokines has first been reported Hillenbrand and colleagues in 2010 describing low concentration of adiponectin and high concentration of resistin (5). In another study, a correlation between these two hormones and the severity of the inflammatory response during sepsis has been demonstrated (6).

Human visceral adipose tissue–derived serpin (i.e. vaspin) is a 47 kDa protein of the serine protease inhibitor family. It has been linked with inflammation, but its exact physiological functions are not yet completely understood. Vaspin was first described as an insulin-sensitizing adipocytokine (7,8). It is considered to promote insulin secretion from pancreatic β-cells (9). Furthermore, it was also demonstrated that vaspin influences circulating levels of the adipocytokines adiponectin and resistin in rats (7). Moreover, vaspin inhibits apoptosis induced by free fatty acids in vascular endothelial cells (10) and expression of pro-inflammatory cytokines (11,12).

Since no data is yet available concerning the possible involvement of vaspin in sepsis, we sought to investigate vaspin concentration in sepsis by comparing the plasma concentrations of the adipocytokine vaspin in patients with sepsis to those of a surgical control group also admitted to the ICU.

 

Materials and methods

 

Subjects

This exploratory study was approved by the Ethics Committee of the Medical University of Vienna and is in accordance to good scientific practice and the Helsinki Declaration. We included 57 patients (35 male patients) with diagnosed sepsis admitted to our General Intensive Care Units of the Department of Anaesthesiology, General Hospital of Vienna, Vienna, Austria, over the period from July 2010 to March 2013. Sepsis, as systemic inflammatory response to infection, was diagnosed using current criteria as defined by the American College of Chest Physicians / Society of Critical Care Medicine (ACCP / SCCM) (13). At least two of the following symptoms as a result of infection need to be present to confirm sepsis diagnosis: 1) a body temperature greater than 38 °C or less than 36 °C, 2) heart rate > 90 beats per minute, 3) respiratory rate > 20 breaths per minute or arterial concentration of CO2 (pCO2) < 32 mm Hg as an indicator of hyperventilation and 4) white blood leukocyte count (WBC) > 12 x 109/ L or < 4 x 109 / L. The control group included 48 patients (37 male patients) admitted to the same ICU after major surgery (ear-nose-throat-, thoracic-, abdominal or orthopaedic surgery). These patients showed no evidence of sepsis.

All patients included were over 18 and under 90 years of age. Pregnant patients and patients suffering from chronic infectious diseases, such as viral hepatitis, HIV infection or autoimmune diseases were not included. Patients were matched by age, sex, weight and existence of diabetes mellitus.

 

Study design

On the day of inclusion, blood samples were obtained from each patient. 4.5 mL of venous blood was drawn and collected in a 1:10 dilution of 0.11 M trisodium citrate (BD, New Jersey, USA). Blood for samples were drawn in the course of routine clinical work. Blood was additionally taken every 24 hours for up to eight days. Due to organisational difficulties it was not possible to get samples for time series analysis from all patients. Samples were centrifuged at 3500 rpm for 15 minutes at 4 °C. The obtained plasma was stored at -80 °C for up to 1.5 years until assayed. All samples were thawed simultaneously only once.

Patient-related data such as sex, age, weight, existence of diabetes mellitus, cause of death, length of stay, WBC, concentration of C-reactive protein (CRP) and the scores of Simplified Acute Physiology Score version II (SAPS II), maximum of Sequential Organ Failure Assessment (SOFA) within the first 24 hours and Acute Physiology and Chronic Health Evaluation version II (APACHE II) scoring systems (severity of illness scoring systems commonly used in intensive care medicine) were obtained from the electronic case documentation system used at our clinic. The scoring systems used are well established for prognostic categorization of septic patients and take into account various physiological parameters such as blood pressure, body temperature, heart rate or blood electrolyte concentrations as well as overall function of specific organ systems, patient-specific risk factors such as chronic health impairments or known organ dysfunction and necessity of therapeutic intervention (14). As is usual for SOFA scoring, the maximum score within the first 24 hours after admission was taken for analysis (14).

 

Methods

Vaspin plasma concentration was measured using a commercially available enzyme-linked immunosorbent assay (ELISA; Vaspin (human) ELISA Kit, AdipoGen, Liestal, Switzerland). The manufacturer’s coefficient of variation (CV) was 1.31% at vaspin plasma concentrations of 0.59 ng/mL, 3.85% at 0.64 ng/mL and 3.64% at 0.71 ng/mL. Plasma samples were randomized before assaying and tested in duplicates, using a dilution of 1:5 according to the manufacturer’s specifications. The assay was performed according to the manufacturer’s manual. Photometric readings were performed using a Victor 3 Microplate Reader (Perkin Elmer, Waltham, USA).

WBC and CRP were quantified at the Department of Laboratory Medicine, certified laboratory of the Medical University of Vienna, using routine tests. WBC values were measured using the Sysmex XE-5000 hematology analyzer (Sysmex, Kobe, Japan). CRP was determined using immunological turbidimetric assay (Tina-quant C-reactive protein latex high sensitive assay, Roche Diagnostics, Rotkreuz, Switzerland).

 

Statistical analysis

Statistical analysis was performed using the open source statistical package “R version 3.0.2” (R Foundation for Statistical Computing, Vienna, Austria).

For each continuous parameter the Shapiro-Wilks normality test was performed. Non-normally distributed parameters were described using median and interquartile range. Since this study was designed as matched case-control study, all comparisons were made using tests for paired samples. Comparison of groups (sepsis vs. control) was performed using the non-parametric Wilcoxon signed rank test, since all data were not normally distributed. Regarding categorical data, the Pearson Chi-squared test was used to compare the groups.

To equalize the characteristics (age, sex, weight, diabetes mellitus) a genetic matching algorithm was applied using the additional package for patient matching “GenMatch” (15,16) to confirm significant differences despite unequal distribution of characteristic parameters of both groups. Using this non-parametric matching method, optimal balance between groups is found using multivariate matching where a genetic search algorithm determines the weight each covariate is given. Friedman test was used to compare daily vaspin plasma concentrations in nine patients for eight continuous days.

 

Results

 

Table 1 describes our study population’s demographic details before and after matching using GenMatch software.

Table 1. Study population demographic before and after matching.

 Table1

 

Plasma vaspin concentration was significantly higher in the sepsis group (0.3 (0.1-0.4) ng/mL) compared to the surgical control group (0.1 (0.0-0.3) ng/mL; P < 0.001). Vaspin concentration showed weak positive correlation with CRP concentration (r = 0.31, P = 0.002), the SAPS II (r = 0.34, P = 0.002) and maximum of SOFA (r = 0.39, P < 0.001) scores, as tested for the overall study population. There was no significant correlation between vaspin and CRP in the septic group alone (r = 0.24, P = 0.066). There was a weak, but statistically significant correlation between vaspin concentration and length of stay (r = 0.26, P = 0.009). No significant difference in plasma vaspin concentrations was observed comparing survivors and non-survivors, in the overall study population (P = 0.33) nor for the septic subgroup alone (P = 0.79). Measured vaspin plasma concentration did not correlate with APACHE II and WBC, neither for the whole of the tested population (APACHE II: r = 0.19, P = 0.12; WBC: r = 0.1, P = 0.3) nor for the septic patients’ (APACHE II: r = -0.08, P = 0.63; WBC: r = 0.07, P = 0.59) or control patients’ subsets (APACHE II: r = 0.02, P = 0.92; WBC: r = -0.15, P = 0.32) alone. Table 2 shows all calculated correlation data. The time series analysis of vaspin plasma concentration of nine patients did not show significant changes (P = 0.32) over eight consecutive days. Figure 1 shows the according plasma concentrations as boxplots.

 

Table 2. Correlation of plasma vaspin concentrations with CRP, WBC and severity-of-illness scoring systems.

 Table2

 

 

 

Figure 1. Vaspin plasma concentration in nine patients for eight continuous days.

The box represents first, second and third quartile. Whiskers indicate minimum and maximum. Circles indicate outliers. X-axis shows days, Y-axis shows vaspin concentration in ng/mL. Labels show median and interquartile range in ng/mL.

 Figure1

 

Discussion

 

To the best of our knowledge this is the first report of plasma vaspin concentration in patients suffering from sepsis. Our data show increased concentrations of plasma vaspin in sepsis as compared to the surgical control group. There was a significant correlation between vaspin and CRP for the overall group of patients. Moreover, we did find a correlation between the SAPS II and the maximum SOFA score with plasma vaspin concentration. Although there was a significantly higher plasma concentration of vaspin in the sepsis group we could not find a significant correlation between vaspin and CRP, while testing for the septic patient group alone.

Sepsis is defined as a systemic inflammatory response syndrome to infection, where infection initiates a complex and prolonged host response, in which both pro-inflammatory and anti-inflammatory mechanisms occur. Pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 extend the inflammatory cascade, directed at eliminating invading pathogens. However, this inflammation may compromise other organ systems (2,3,17).

Recently, the visceral adipose tissue came to attention as a source of adipose-derived hormones and adipocytokines which may have a role in the development of systemic inflammatory response during sepsis (5,6,18).

Vaspin is member of the serine protease inhibitor family and is expressed in visceral adipose tissue of Otsuka Long-Evans Tokushima fatty rats in obesity, when insulin plasma concentrations are high (7). In humans, elevated vaspin concentrations are associated with obesity as well as impaired insulin sensitivity, whereas low vaspin concentration is indicative of a high level of fitness (19). The exact mechanisms how vaspin secretion influences the glucose metabolism and insulin sensitivity are not entirely understood.

We did find significantly increased vaspin plasma concentrations in septic patients as compared to the control group. However, the mechanism behind higher plasma vaspin concentration was not investigated in this study. Since vaspin also exerts anti-inflammatory properties, like the suppression of TNF-alpha (similar to the inflammatory adipocytokines leptin and resistin) (7), it would be conceivable that the increased vaspin plasma concentration is a consequence of the increase of pro-inflammatory cytokines during sepsis and therefore vaspin release belongs to the anti-inflammatory mechanisms during sepsis. Interestingly plasma vaspin also correlated with the CRP concentration in our patients. However, this correlation should be interpreted with caution, as it was weak and only available for the overall study population. These results are in contrast with our previous findings: we showed elevated plasma concentration of zonulin, a protein regulating gut wall permeability which is associated with poor insulin sensitivity, in septic patients. For zonulin however, there were no correlations between plasma concentration and biomarkers of inflammation or severity-of-illness scoring systems (20).

Vaspin, like resistin and adiponectin, correlates with the SAPS II and maximum of SOFA scoring systems during sepsis (5). We were able to demonstrate statistically significant correlations of equal strength as in the aforementioned study between concentration of vaspin and those scores in our study patients.

The present study has some limitations. Vaspin concentration was only measured in plasma. As there is limited knowledge about molecular targets, elimination or distribution of vaspin, plasma concentration may not be representative of function or quantity of vaspin in other tissues.

Since only nine patients were included for time line analysis, this sample size is too small for proper inference about the dynamics of vaspin concentrations after the first day of diagnosis of sepsis. We also state that some of our septic patients have been included in our previous study exploring zonulin plasma concentrations as a potential marker for gut wall integrity in sepsis. However, aliquoted samples were only used once. Lastly, as the recruitment of patients lasted for 1.5 years, unknown stability issues could affect the measurement of vaspin.

In conclusion, our data provide evidence that plasma vaspin concentration is significantly increased in septic patients as compared to non-septic ICU patients. Vaspin release may belong to the anti-inflammatory mechanisms during sepsis. Our results, however, warrant further larger clinical studies to elucidate vaspin’s function during sepsis, especially the role of vaspin in the monitoring of the course and severity of the disease.

Notes

Potential conflict of interest

None declared.

References

 1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29:S109–S116. http://dx.doi.org/10.1097/00003246-200107001-00035.

 2. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51. Review. Erratum in: N Engl J Med 2013;369:2069. http://dx.doi.org/10.1056/NEJMra1208623.

 3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10 http://dx.doi.org/10.1097/00003246-200107000-00002.

 4. Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al. Milwaukee Initiative in Critical Care Outcomes Research Group of Investigators. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011;140:1223-31. http://dx.doi.org/10.1378/chest.11-0352.

 5. Hillenbrand A, Knippschild U, Weiss M, Schrezenmeier H, Henne-Bruns D, Huber-Lang M, et al. Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg 2010;10:26. http://dx.doi.org/10.1186/1471-2482-10-26.

 6. Vassiliadi DA, Tzanela M, Kotanidou A, Orfanos SE, Nikitas N, Armaganidis A, et al. Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care 2012 ;27:400-9. http://dx.doi.org/10.1016/j.jcrc.2012.04.007.

 7. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci 2005;102:10610–5. http://dx.doi.org/10.1073/pnas.0504703102.

 8. Gao FF, Liu GL, Zheng RX, Jiang LH, Bao PL. [Correlation between vaspin concentration and insulin sensitivity in the visceral adipose tissue of young obese rats]. Zhongguo Dang Dai Er Ke Za Zhi 2013;15:71-4.

 9. Kovacs P, Miehle K, Sandner B, Stumvoll M, Blüher M. Insulin administration acutely decreases vaspin serum concentrations in humans. Obes Facts 2013;6:86-8. http://dx.doi.org/10.1159/000348836.

10. Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM, Lee YL, et al. Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun 2011;413:264-9. http://dx.doi.org/10.1016/j.bbrc.2011.08.083.

11. Yamawaki H. Vascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses. Biol Pharm Bull 2011;34:307–310. http://dx.doi.org/10.1248/bpb.34.307.

12. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 2011;12:60. http://dx.doi.org/10.1186/1471-2350-12-60.

13. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. ACCP / SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP / SCCM Consensus Conference Committee. American College of Chest Physicians / Society of Critical Care Medicine. Chest 1992;136:e28.

14. Moemen ME. Prognostic categorization of intensive care septic patients. World J Crit Care Med 2012;1:67-79. http://dx.doi.org/10.5492/wjccm.v1.i3.67.

15. Sekhon JS. Multivariate and Propensity Score Matching Software with Automated Balance Optimization. Journal of Statistical Software 2011;42:1-52.

16. Diamond A, Sekhon JS. Genetic Matching for Estimating Causal Effects: A General Multivariate Matching Method for Achieving Balance in Observational Studies. Review of Economics and Statistics 2013;95:932-45. http://dx.doi.org/10.1162/REST_a_00318.

17. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008;8:32-43. http://dx.doi.org/10.1016/S1473-3099(07)70265-7.

18. Venkatesh B, Hickman I, Nisbet J, Cohen J, Prins J. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 2009;13:R105. http://dx.doi.org/10.1186/cc7941.

19. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008;57:372-7. http://dx.doi.org/10.2337/db07-1045.

20. Klaus DA, Motal MC, Burger-Klepp U, Marschalek C,  Schmidt EM, Lebherz-Eichinger D, et al. Increased plasma zonulin in patients with sepsis. Biochem Med 2013;23:107-11. http://dx.doi.org/10.11613/BM.2013.013.